No profile data available.
MDxHealth SA (MDXH) is a healthcare company in the DNA testing equipment industry, based in Herstal, Belgium, with about 364 full-time employees.
It reported revenue of $90.05 million for fiscal year 2024, up 28.3% from fiscal year 2023, and net income of -$38.07 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $27.43 million, up 17.6% from a year before. Its market capitalization was $56.27 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDxHealth SA reported $90.05 million in revenue for fiscal year 2024, up 28.3% from $70.19 million in fiscal year 2023. In Q3 2025 revenue was $27.43 million.
$56.27 million as of October 9, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include Burning Rock Biotech Limited (BNR), Cardiff Oncology, Inc. (CRDF), Sera Prognostics, Inc. (SERA), PAVmed Inc. (PAVM).